China Digital Health Market Outlook and Forecast to 2033 – Electronic Health Records, Regulatory Approved Apps and Telehealth

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report Download FREE Resources

Published: August 05, 2024 Report Code: GDME0108MDB-ST

Select Item

China Digital Health Market Report Overview

The digital health market size in China was $260.3 million in 2023. Digital health refers to the utilization of information and communication technologies in medicine and other health-related fields to control diseases and health risks and to encourage well-being. It has a broad scope and includes the use of wearable devices, mobile health, telehealth, health information technology, and telemedicine.

China Digital Health Market Outlook, 2023-2033 ($ Million)

China Digital Health Market Outlook, 2023-2033 ($ Million)

Buy the Full Report for More Insights into the China Digital Health Market Forecast

Download a Free Sample Report

The China digital health market research report provides value, volume, and average prices within the Chinese market. The report also includes a comprehensive analysis of distribution channels, leading companies, and financial deals landscape within the China digital health market.

Market Size (2023) $260.3 million
Historic Period 2018-2022
Forecast Period 2023-2033
Key Categories ·        Electronic Health Records

·        Telehealth

·        Regulatory Approved Apps
Key Companies ·        Cerner Corp

·        Concentrix Corp

·        Teladoc Health Inc

·        Siemens Healthineers AG

·        Constellation Software Inc
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

China Digital Health Market Categories

The key categories in the China digital health market are electronic health records, telehealth, and regulatory approved apps. In 2023, the electronic health records category was the highest revenue contributor in the China digital health market. An electronic health record is an electronic version of a patient’s medical history that is kept over time by the provider. It includes critical administrative clinical data such as demographics, progress notes, issues, and prescriptions related to a patient’s treatment under a specific provider. Additionally, electronic health records comprise vital signs, prior medical history, vaccinations, laboratory results, and radiology reports. The electronic health records market includes cloud-based systems and remote systems.

China Digital Health Market Analysis by Categories, 2023 (%)

China Digital Health Market Analysis by Categories, 2023 (%)

Buy the Full Report for More Category Insights into the China Digital Health Market
Download a Free Sample Report

China Digital Health Market- Competitive Landscape

A few of the leading companies in China digital health market are:

  • Cerner Corp
  • Concentrix Corp
  • Teladoc Health Inc
  • Siemens Healthineers AG
  • Constellation Software Inc

In 2023, Cerner Corp was the highest revenue contributor in the China digital health market. Headquartered in North Kansas City, Missouri, the US, Cerner Corp, a subsidiary of Oracle Corporation, is a provider of healthcare information technology solutions and related services. The company offers a comprehensive range of solutions and services that assist the clinical, financial, and operational needs of organizations. Its major solutions include ambulatory, critical care, acute EHR solutions, women’s health, customer relationship management, patient engagement, and revenue cycle management. Furthermore, the company offers solutions on the unified Cerner Millennium architecture and the HealtheIntent cloud-based platform.

China Digital Health Market Analysis by Companies, 2023 (%)

China Digital Health Market Analysis by Companies, 2023 (%)

Buy the Full Report for More Company Insights into the China Digital Health Market
Download a Free Sample Report

Segments Covered in the Report

China Digital Health Category Outlook (Value, $ Million, 2018-2033)

  • Electronic Health Records
  • Telehealth
  • Regulatory Approved Apps

Scope

The China digital health market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.

  • 2023 company share and distribution share data for digital health market.

  • Global corporate-level profiles of key companies operating within the China digital health market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Reasons to Buy

  • Business strategies by identifying the key market segments poised for strong growth in the future.

  • Develop market-entry and market expansion strategies.

  • Design competition strategies by identifying who-stands-where in the market.

  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

  • Understand the key distribution channels and what’s the most preferred mode of product distribution – identify, understand and capitalize.

Key companies covered in the “China Digital Health Outlook to 2033” report:
• Cerner Corp
• Concentrix Corp
• Teladoc Health Inc

Table of Contents

|1 Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 7

2 Introduction 9

2.1 What Is This Report About? 9

2.2 Digital Health Market Segmentation 9

2.3 Definitions of Markets Covered in the Report 10

3 Digital Health Market, China 13

3.1 Digital Health Market, China, Revenue ($m), 2018-2033 13

3.2 Digital Health Market, China, Revenue Mix ($m), 2023 14

3.3 Digital Health Market, China, Category Contribution by Revenue ($m), 2023 15

3.4 Digital Health Market, China, Revenue ($m), 2018-2033 16

3.5 Digital Health Market, China, Volume (Units), 2018-2033 18

3.6 Digital Health Market, China, Volume (Units), 2018-2033 20

3.7 Digital Health Market, China, Company Share by Revenue ($m), 2023 22

4 Electronic Health Records Market, China 24

4.1 Electronic Health Records Market, China, Revenue Mix ($m), 2023 24

4.2 Electronic Health Records Market, China, Segment Contribution (%), 2023 25

4.3 Electronic Health Records Market, China, Revenue ($m), 2018-2033 27

4.4 Electronic Health Records Market, China, Volume (Units), 2018-2033 29

4.5 Electronic Health Records Market, China, Average Price ($), 2018-2033 31

4.6 Electronic Health Records Market, China, Distribution Share by Revenue ($m), 2023 32

4.7 Electronic Health Records Market, China, Company Share by Revenue ($m), 2023 33

5 Regulatory Approved Apps Market, China 34

5.1 Regulatory Approved Apps Market, China, Revenue ($m), 2025-2033 34

5.1.1 Clinical-Focused Apps Market, China, Revenue ($m), by Segment, 2025-2033 36

5.1.2 Indication Specific Mobile Apps Market, China, Revenue ($m), by Segment, 2025-2033 38

5.1.3 Clinical-Focused Apps Market, China, Volume (Units) by Segment, 2025-2033 42

5.1.4 Indication Specific Mobile Apps Market, China, Volume (Units) by Segment, 2025-2033 44

5.2 Regulatory Approved Apps Market, China, Average Price ($), 2025-2033 46

6 Telehealth Market, China 48

6.1 Telehealth Market, China, Revenue Mix ($m), 2023 48

6.2 Telehealth Market, China, Segment Contribution (%), 2023 49

6.3 Telehealth Market, China, Revenue ($m), 2018-2033 51

6.4 Telehealth Market, China, Volume (Units), 2018-2033 53

6.5 Telehealth Market, China, Average Price ($), 2018-2033 55

6.6 Telehealth Market, China, Distribution Share by Revenue ($m), 2023 56

6.7 Telehealth Market, China, Company Share by Revenue ($m), 2023 57

7 Overview of Key Companies in China, Digital Health Market 58

7.1 Teladoc Health Inc 58

7.1.1 Company Overview 58

7.2 Cerner Corp 58

7.2.1 Company Overview 58

7.3 Concentrix Corp 58

7.3.1 Company Overview 58

7.4 Siemens Healthineers AG 59

7.4.1 Company Overview 59

7.5 Philips Healthcare Informatics Inc 59

7.5.1 Company Overview 59

7.6 Constellation Software Inc 59

7.6.1 Company Overview 59

8 Digital Health Market Pipeline Products 60

9 Financial Deals Landscape 64

9.1 Acquisition 64

9.1.1 The9 to Acquire Additional

21.7% in WM Therapeutic for USD1.4 Billion 64

9.1.2 Tigerjet Acquires Nengsheng (Shanghai) Medical Device Technology Consulting (NAMSA China) 66

9.1.3 Tibet Duo Rui Pharma to Acquire 51% Stake in Hongxi Medical Technology (Tianjin) 67

9.1.4 GKHT Medical Technology to Acquire Remaining

17.2% Stake in Hunan Guoke Hengtai Medical Technology from Changsha Huizhong Enterprise Management Consulting for USD0.26 Million 68

9.1.5 APT Pharma (China) to Acquire 19% Stake in Beijing Xinlejia International Health Technology from Mighty Century for USD2.2 Million 69

9.2 Equity Offerings 70

9.2.1 Shanghai Rundu Biotechnology to Raise USD1.38 Million in Private Placement of Shares 70

9.2.2 iFLYTEK to Spin off iFLYTEK Medical 71

9.2.3 Guangzhou Fangxin Medical Technology Raises More than USD1.36 Million Equity Financing 73

9.3 Partnerships 74

9.3.1 Shenzhen Zhong Ji Health Science and Sichuan Zhongji Guande Biotechnology to form Joint Venture with Sichuan Zhongnongyun Qihang Data Technology 74

9.3.2 Sanyou Bio Enters into Co-Development Agremeent with BioGeometry 75

9.3.3 Tianzhihang Plans to form Join Joint Venture Agreement with Beijing Ruihuachen Medical Technology 76

9.3.4 SMK Enters into Licensing Agreement with Canary Speech 77

9.3.5 InnoMax Medical Technology Enters into Licensing Agreement with Belluscura 78

9.3.6 HitGen Enters into Agreement with Nested Therapeutics 79

9.4 Venture Financing 80

9.4.1 Beijing Touche Future Technology (Thorough Future) Secures USD13.8 Million in Series A+ Financing 80

9.4.2 Kangyuan Medical Technology (Dalian) Raises Funds through Venture Financing 82

9.4.3 Suzhou Aimi Life Science Technology (Amystron, AIMAISI and Aimi) Raises Funds through Angel Financing 83

9.4.4 Cipher Gene (SafeGene) Raises USD13.8 Million Series C Financing 84

9.4.5 Beijing Qingyuan Kaiwu Technology Secures Pre-Series A+ Financing 85

9.4.6 Qingdao Future Mobile Medical Technology Raises Funds through Series B Financing 86

9.4.7 Bigway Medical Secures USD0.69 Million in Series B Financing 87

9.4.8 Shenzhen Jinhe Biology Raises Funds through Venture Financing 88

9.4.9 Suzhou Zhongxi Bioinformatics (Zhongji) Secures Pre-Series A++ Funding 90

9.4.10 Shanghai Zhongke New Life Biological Technology (Zhongke New Life) Secures Series C Funding 91

9.4.11 The CareVoice Secures USD10 Million in Series B Funding 92

9.4.12 Shangzhi Medical Raises Funds through Venture Financing 94

9.4.13 Xiamen Longjin Biotechnology (Longjin Biotechnology) Secures USD4.44 Million in Venture Funding 95

9.4.14 Shenzhen Dingjia Medical Technology (Dingjia Medical) Raises in Series A Funding 96

9.4.15 Weimai Intelligent Technology Raises Funds through Series A Financing 97

9.4.16 Beijing Guoyi Medical Alliance Raises Funds in Series A Funding 98

9.4.17 Guangzhou Baishi Medical Technology (BioScience Medical) Raises USD12.66 Million in Series B Financing 99

9.4.18 Beijing Huimei Technology Raises USD9.83 Million Yuan Investment from Newerly Capital 100

9.4.19 Pengyang Medical Raises USD1.405 Million in Series B++ Financing 101

9.4.20 Guangdong Hiskal Medical Technology Raises Up to USD13.99 Million in Series A Financing 102

9.4.21 Qijia Technology (Suzhou) Raises Funds through Angel Financing 104

9.4.22 Saifukere Raises Fund through Pre-Series A Financing 105

9.4.23 Zhongshan Kangzhi Xinyuan Medical Technology Secures Funds in Venture Financing 106

9.4.24 Jiuzhi Technology Raises Funds in Series A Financing 107

9.4.25 Shanghai Xuanyan Biotechnology (Xuanyan Biotechnology) Raises Fund through Angel Financing 108

9.4.26 Beijing Jinen Maternal and Infant Health Information Technology (JEAN Jinen Health) Completes Series A Funding 109

9.4.27 Particle Cloud Biotechnology (Point Cloud Biotech) Secures Series B+ Financing 110

9.4.28 SPH Health Commerce Completes USD68.5 Million in Series C financing 111

9.4.29 Beijing Shunchang Shengshi Medical Secures USD6.94 Million in Venture Financing 112

9.4.30 Hunan Longgang Intelligent Technology Raises Funds through Angle Financing 113

9.4.31 Sichuan Pangu Smart Medical Technology (PANGU Medical, Bangu Medical, Bangkok Medical) Secures Series A Funding 114

9.4.32 Jiangsu Wenji Information Technology (Wenji Dental Network) Raises USD27.42 Million in Pre-Series A Financing 115

9.4.33 Hangzhou Knowledge Matrix Information Technology Raises Funds through Series A Financing 116

9.4.34 Shenzhen Shengqiang Technology Raises Up to USD13.62 Million in Series B Financing 117

9.4.35 Beijing Leo Dingfeng Biotechnology (Leo Science, Leo Summit) Secures Pre-Series A Venture Funding 118

9.4.36 Guangzhou Meiyang Innovation Technology (MIRA) Raises USD13.78 Million in Pre-Series A Financing 119

9.4.37 Yipin (Guiyang) Quality Technology Secures Additional Fund through Series C Financing 120

9.4.38 Suzhou Peixin Technology (Pixin Technology) Secures Funds in Pre-Series A Financing 121

9.4.39 Gaowei Pharma (Gaowei Medicine) Raises Funds through Angel Financing 122

9.4.40 Wisdom Future (Guangzhou) Intelligent (ChromX Health, Smart future) Secures Pre-Series A Funding 123

9.4.41 Zhimoxing Internet Technology (Wisdom Star Internet Technology) Completes Angel Funding 125

9.4.42 CloudMinds (Data Robot, Dart Robot) Secures Approximately USD138 Million in Series C Funding 126

9.4.43 Preh Benchmark Technology (Precision Scientific) Raises USD13.92 Million in Series C Financing 127

9.4.44 Beijing Thorough Future Technology Raises USD13.92 Million in Series A Venture Funding 128

10 Appendix 129

10.1 Research Methodology 130

10.1.1 Coverage 130

10.1.2 Secondary Research 130

10.1.3 Primary Research 131

10.1.4 Market Modeling and Forecasting 132

10.1.5 Company Share Analysis 133

10.1.6 Distribution Share Analysis 133

10.1.7 Benchmarking 134

10.2 GlobalData Consulting 134

10.3 Contact Us 135

10.4 Disclaimer 135

Table

|1.1 List of Tables

Table 1: Digital Health Market, China, Revenue ($m), USD Constant, 2018-2033 13

Table 2: Digital Health Market, China, Category Contribution by Revenue ($m), 2023 15

Table 3: Digital Health Market, China, Revenue ($m), USD Constant, Historic, 2018-2033 17

Table 4: Digital Health Market, China, Volume (Units), 2018-2033 19

Table 5: Digital Health Market, China, Volume (Units), Historic, 2018-2033 21

Table 6: Digital Health Market, China, Company Share by Revenue ($m), USD Constant, 2023 23

Table 7: Electronic Health Records Market, China, Segment Contribution (%), 2023 26

Table 8: Electronic Health Records Market, China, Revenue ($m), USD Constant, 2018-2033 28

Table 9: Electronic Health Records Market, China, Volume (Units), 2018-2033 30

Table 10: Electronic Health Records Market, China, Average Price ($), 2018-2033 31

Table 11: Electronic Health Records Market, China, Distribution Share by Revenue ($m), USD Constant, 2023 32

Table 12: Electronic Health Records Market, China, Company Share by Revenue ($m), USD Constant, 2023 33

Table 13: Regulatory Approved Apps Market, China, Revenue ($m), USD Constant, 2025-2033 35

Table 14: Clinical-Focused Apps Market, China, Revenue ($m), USD Constant, 2025-2033 37

Table 15: Indication Specific Mobile Apps Market, China, Revenue ($m), USD Constant, Historic, 39

Table 16: Regulatory Approved Apps Market, China, Volume (Units), 2025-2033 41

Table 17: Clinical-Focused Apps Market, China, Volume (Units), 2025-2033 43

Table 18: Indication Specific Mobile Apps Market, China, Volume (Units), 2025-2033 45

Table 19: Regulatory Approved Apps Market, China, Average Price ($), 2025-2033 46

Table 20: Telehealth Market, China, Segment Contribution (%), 2023 50

Table 21: Telehealth Market, China, Revenue ($m), USD Constant, 2018-2033 52

Table 22: Telehealth Market, China, Volume (Units), 2018-2033 54

Table 23: Telehealth Market, China, Average Price ($), 2018-2033 55

Table 24: Telehealth Market, China, Distribution Share by Revenue ($m), USD Constant, 2023 56

Table 25: Telehealth Market, China, Company Share by Revenue ($m), USD Constant, 2023 57

Table 26: Digital Health Market Pipeline Products 60

Table 27: The9 to Acquire Additional 21.7% in WM Therapeutic for USD1.4 Billion 64

Table 28: Tigerjet Acquires Nengsheng (Shanghai) Medical Device Technology Consulting (NAMSA China) 66

Table 29: Tibet Duo Rui Pharma to Acquire 51% Stake in Hongxi Medical Technology (Tianjin) 67

Table 30: GKHT Medical Technology to Acquire Remaining 17.2% Stake in Hunan Guoke Hengtai Medical Technology from Changsha Huizhong Enterprise Management Consulting for USD0.26 Million 68

Table 31: APT Pharma (China) to Acquire 19% Stake in Beijing Xinlejia International Health Technology from Mighty Century for USD2.2 Million 69

Table 32: Shanghai Rundu Biotechnology to Raise USD1.38 Million in Private Placement of Shares 70

Table 33: iFLYTEK to Spin off iFLYTEK Medical 71

Table 34: Guangzhou Fangxin Medical Technology Raises More than USD1.36 Million Equity Financing 73

Table 35: Shenzhen Zhong Ji Health Science and Sichuan Zhongji Guande Biotechnology to form Joint Venture with Sichuan Zhongnongyun Qihang Data Technology 74

Table 36: Sanyou Bio Enters into Co-Development Agremeent with BioGeometry 75

Table 37: Tianzhihang Plans to form Join Joint Venture Agreement with Beijing Ruihuachen Medical Technology 76

Table 38: SMK Enters into Licensing Agreement with Canary Speech 77

Table 39: InnoMax Medical Technology Enters into Licensing Agreement with Belluscura 78

Table 40: HitGen Enters into Agreement with Nested Therapeutics 79

Table 41: Beijing Touche Future Technology (Thorough Future) Secures USD13.8 Million in Series A+ Financing 80

Table 42: Kangyuan Medical Technology (Dalian) Raises Funds through Venture Financing 82

Table 43: Suzhou Aimi Life Science Technology (Amystron, AIMAISI and Aimi) Raises Funds through Angel Financing 83

Table 44: Cipher Gene (SafeGene) Raises USD13.8 Million Series C Financing 84

Table 45: Beijing Qingyuan Kaiwu Technology Secures Pre-Series A+ Financing 85

Table 46: Qingdao Future Mobile Medical Technology Raises Funds through Series B Financing 86

Table 47: Bigway Medical Secures USD0.69 Million in Series B Financing 87

Table 48: Shenzhen Jinhe Biology Raises Funds through Venture Financing 88

Table 49: Suzhou Zhongxi Bioinformatics (Zhongji) Secures Pre-Series A++ Funding 90

Table 50: Shanghai Zhongke New Life Biological Technology (Zhongke New Life) Secures Series C Funding 91

Table 51: The CareVoice Secures USD10 Million in Series B Funding 92

Table 52: Shangzhi Medical Raises Funds through Venture Financing 94

Table 53: Xiamen Longjin Biotechnology (Longjin Biotechnology) Secures USD4.44 Million in Venture Funding 95

Table 54: Shenzhen Dingjia Medical Technology (Dingjia Medical) Raises in Series A Funding 96

Table 55: Weimai Intelligent Technology Raises Funds through Series A Financing 97

Table 56: Beijing Guoyi Medical Alliance Raises Funds in Series A Funding 98

Table 57: Guangzhou Baishi Medical Technology (BioScience Medical) Raises USD12.66 Million in Series B Financing 99

Table 58: Beijing Huimei Technology Raises USD9.83 Million Yuan Investment from Newerly Capital 100

Table 59: Pengyang Medical Raises USD1.405 Million in Series B++ Financing 101

Table 60: Guangdong Hiskal Medical Technology Raises Up to USD13.99 Million in Series A Financing 102

Table 61: Qijia Technology (Suzhou) Raises Funds through Angel Financing 104

Table 62: Saifukere Raises Fund through Pre-Series A Financing 105

Table 63: Zhongshan Kangzhi Xinyuan Medical Technology Secures Funds in Venture Financing 106

Table 64: Jiuzhi Technology Raises Funds in Series A Financing 107

Table 65: Shanghai Xuanyan Biotechnology (Xuanyan Biotechnology) Raises Fund through Angel Financing 108

Table 66: Beijing Jinen Maternal and Infant Health Information Technology (JEAN Jinen Health) Completes Series A Funding 109

Table 67: Particle Cloud Biotechnology (Point Cloud Biotech) Secures Series B+ Financing 110

Table 68: SPH Health Commerce Completes USD68.5 Million in Series C financing 111

Table 69: Beijing Shunchang Shengshi Medical Secures USD6.94 Million in Venture Financing 112

Table 70: Hunan Longgang Intelligent Technology Raises Funds through Angle Financing 113

Table 71: Sichuan Pangu Smart Medical Technology (PANGU Medical, Bangu Medical, Bangkok Medical) Secures Series A Funding 114

Table 72: Jiangsu Wenji Information Technology (Wenji Dental Network) Raises USD27.42 Million in Pre-Series A Financing 115

Table 73: Hangzhou Knowledge Matrix Information Technology Raises Funds through Series A Financing 116

Table 74: Shenzhen Shengqiang Technology Raises Up to USD13.62 Million in Series B Financing 117

Table 75: Beijing Leo Dingfeng Biotechnology (Leo Science, Leo Summit) Secures Pre-Series A Venture Funding 118

Table 76: Guangzhou Meiyang Innovation Technology (MIRA) Raises USD13.78 Million in Pre-Series A Financing 119

Table 77: Yipin (Guiyang) Quality Technology Secures Additional Fund through Series C Financing 120

Table 78: Suzhou Peixin Technology (Pixin Technology) Secures Funds in Pre-Series A Financing 121

Table 79: Gaowei Pharma (Gaowei Medicine) Raises Funds through Angel Financing 122

Table 80: Wisdom Future (Guangzhou) Intelligent (ChromX Health, Smart future) Secures Pre-Series A Funding 123

Table 81: Zhimoxing Internet Technology (Wisdom Star Internet Technology) Completes Angel Funding 125

Table 82: CloudMinds (Data Robot, Dart Robot) Secures Approximately USD138 Million in Series C Funding 126

Table 83: Preh Benchmark Technology (Precision Scientific) Raises USD13.92 Million in Series C Financing 127

Table 84: Beijing Thorough Future Technology Raises USD13.92 Million in Series A Venture Funding 128

Table 85: Total Number of Primary Research Participants, Digital Health Market, by Country 131

Figures

|1.2 List of Figures

Figure 1: Digital Health Market, China, Revenue ($m), USD Constant, 2018-2033 13

Figure 2: Digital Health Market, China, Revenue Mix ($m), 2023 14

Figure 3: Digital Health Market, China, Category Contribution (%), 2023 15

Figure 4: Digital Health Market, China, Revenue ($m), USD Constant, Historic, 2018-2033 16

Figure 5: Digital Health Market, China, Volume (Units), 2018-2033 18

Figure 6: Digital Health Market, China, Volume (Units), Historic, 2018-2033 20

Figure 7: Digital Health Market, China, Company Share (%) 2023 22

Figure 8: Electronic Health Records Market, China, Revenue Mix ($m), 2023 24

Figure 9: Electronic Health Records Market, China, Segment Contribution (%), 2023 25

Figure 10: Electronic Health Records Market, China, Revenue ($m), USD Constant, 2018-2033 27

Figure 11: Electronic Health Records Market, China, Volume (Units), 2018-2033 29

Figure 12: Electronic Health Records Market, China, Company Share (%) 2023 33

Figure 13: Regulatory Approved Apps Market, China, Revenue ($m), USD Constant, 2025-2033 34

Figure 14: Clinical-Focused Apps Market, China, Revenue ($m), USD Constant, 2025-2033 36

Figure 15: Indication Specific Mobile Apps Market, China, Revenue ($m), USD Constant, 2025-2033 38

Figure 16: Regulatory Approved Apps Market, China, Volume (Units), 2025-2033 40

Figure 17: Clinical-Focused Apps Market, China, Volume (Units), 2025-2033 42

Figure 18: Indication Specific Mobile Apps Market, China, Volume (Units), 2025-2033 44

Figure 19: Telehealth Market, China, Revenue Mix ($m), 2023 48

Figure 20: Telehealth Market, China, Segment Contribution (%), 2023 49

Figure 21: Telehealth Market, China, Revenue ($m), USD Constant, 2018-2033 51

Figure 22: Telehealth Market, China, Volume (Units), 2018-2033 53

Figure 23: Telehealth Market, China, Company Share (%) 2023 57

Frequently asked questions

China Digital Health Market Outlook and Forecast to 2033 – Electronic Health Records, Regulatory Approved Apps and Telehealth standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

China Digital Health Market Outlook and Forecast to 2033 – Electronic Health Records, Regulatory Approved Apps and Telehealth was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Digital Health reports
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Medical Devices
New
Traditional Wound Management Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | June 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at China Digital Health Market Outlook and Forecast to 2033 – Electronic Health Records, Regulatory Approved Apps and Telehealth in real time.

  • Access a live China Digital Health Market Outlook and Forecast to 2033 – Electronic Health Records, Regulatory Approved Apps and Telehealth dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more